Meanwhile, reactive oxygen species (ROS) can reactive ERK1/2, which is located at the center of MAPK pathway, indicating that ROS plays a crucial role in the resistance of BRAF and MEK inhibitors in BRAF mutation melanoma [379, 380]. This evidence concerns the gene MAP2K7 and melanoma.